The ASEAN Medical Device Directive, and how Malaysia applies it.
The AMDD is the ASEAN agreement that gives the region one definition of a medical device, four risk classes, common essential principles, one dossier format (the CSDT), a post-market alert system and a common Declaration of Conformity. It sets the framework; each country still registers devices under its own law. Here is what each article and annex requires, where it sits in Malaysia’s Act 737 and Medical Device Regulations 2012, and what it does not do for you.
What the AMDD is.
The ASEAN Agreement on Medical Device Directive was signed in Bangkok on 21 November 2014 by ministers of all ten ASEAN member states. Under Article 22 it entered into force on 1 January 2015, but only among the states that have ratified or accepted it. It has 24 articles and 8 annexes, and the annexes are part of the Agreement (Article 23). Member states may make no reservations (Article 21). The ASEAN Medical Device Committee (AMDC), made up of each country’s regulator, oversees implementation (Article 14).
The core obligations are short. Only devices that conform to the Agreement may be placed on a member state’s market; the person placing the device, or the authorised representative, must register it with that country’s regulator; and that person must be licensed before placing it on the market (Articles 1, 6 and 7). In Malaysia those three duties are device registration under section 5 of Act 737, the establishment licence under section 15, and, for a foreign manufacturer, an authorised representative.
The eight annexes and their Malaysian counterparts
| AMDD annex | What it sets | Where it sits in Malaysia |
|---|---|---|
| 1 Essential Principles | Safety and performance requirements every device must meet (Article 3) | Act 737 s.4(a); MDR 2012 Third Schedule, Appendix 1; MDA/GD/0007 |
| 2 Classification rules (non-IVD) | 16 rules, Classes A–D (Article 4) | Act 737 s.3; MDR 2012 First Schedule; MDA/GD/0062 harmonised list |
| 3 Classification rules (IVD) | 7 rules, Classes A–D | MDR 2012 First Schedule (IVD rules); MDA/GD/0062 |
| 4 ASEAN CSDT | Common dossier format (Article 8(a)) | MDR 2012 Third Schedule, Appendix 2; MDA/GD/0008 and GD/0004 (IVD) |
| 5 Post Marketing Alert System | Distribution and complaint records, adverse event reporting, FSCA (Articles 8(b), 12) | Act 737 ss.37–42; MDA/GD/0067 for exchange between ASEAN regulators |
| 6 Declaration of Conformity | Required elements of the manufacturer’s DoC (Article 8(c)) | MDR 2012 Third Schedule, Appendix 3; MDA/GD/0025 |
| 7 Labelling | Labelling requirements states may adopt; national languages allowed (Article 10) | MDR 2012 Sixth Schedule; MDA/GD/0026 |
| 8 Clinical Investigation | Procedure regulators may require for device studies (Article 13) | Exemption from registration for clinical research, Exemption Order 2024 para 3(1)(d) |
The Malaysian column follows MDA’s own comparison of the AMDD with Act 737 and the Medical Device Regulations 2012, which concludes that Malaysia has carried almost all of the AMDD’s articles into Act 737. The detail pages: CSDT and technical file, Declaration of Conformity, labelling and classification.
Article by article: what Malaysia does with it
| AMDD article | Requirement | Malaysia |
|---|---|---|
| Art. 2 | Definition of a medical device, product owner, authorised representative | Act 737 s.2; MDA says the definitions are in line (MDA/GD/0063) |
| Art. 4(5) | The national regulator settles classification disputes; its decision is final | Act 737 s.3(2): disputes between an establishment and a CAB go to MDA |
| Art. 5 | Assessment by the regulator or bodies it recognises | Registered conformity assessment bodies (Act 737 ss.7, 10–14); Class A exempt from CAB assessment (Exemption Order 2024 para 5) |
| Art. 6(4) | Custom-made devices are not subject to product registration | Exempt from registration (Exemption Order 2024 para 3(1)(h)), but an exemption application to MDA is required |
| Art. 6(5) | Regulator may authorise unregistered devices in the interest of public health | Special access medical devices (Exemption Order 2024 para 3(1)(i)) |
| Art. 9 | Recognised standards give a presumption of conformity with the essential principles | Standards recognised by MDA (MDA/GD/0008) |
| Art. 10(3) | States may require labels in their national language | Bahasa Malaysia required for home-use devices (MDR 2012 Sixth Schedule, Part II, item 5(1)) |
| Art. 11 | Claims are regulated and must be justified by evidence | Act 737 s.44 bans misleading claims; see advertisement approval |
| Art. 12 | Traceability records, adverse event reports, FSCA notification | Act 737 ss.37–42 (distribution records, PMS, complaints, problem reporting, FCA, recall) |
| Art. 17(2) | States may refuse refurbished devices | Malaysia regulates them instead: refurbished devices must be registered |
One Malaysian rule goes further than the AMDD text: Act 737 section 5 requires registration before a device is exported, not only before it is placed on the market. Export-only devices use the exemption in paragraph 3(1)(f) of the Exemption Order 2024 instead; see export certificates.
Classification: four classes and a harmonised list
- Four classes (Article 4): A low, B low-moderate, C moderate-high, D high.
- Annex 2, 16 rules: non-invasive (1–4), invasive (5–8), active (9–12) and additional rules (13–16), for example rule 13 (devices with an ancillary medicinal substance are Class D) and rule 16 (contraceptive devices are Class C, or D if implantable or long-term invasive). Standalone software that is a medical device counts as an active device.
- Annex 3, 7 rules for IVD medical devices.
- Where more than one class could apply, the highest applies; devices used together are each classified separately; a device with several intended purposes takes the class of the most critical one (Article 4(2)–(4)).
- A member state that reclassifies a device or applies the rules differently must notify the AMDC with its reasons (Article 4(6)).
Malaysia’s First Schedule follows the same structure: 16 rules for general devices and 7 for IVDs. The AMDC also agrees classes for named device types. MDA publishes these in MDA/GD/0062, Harmonised Classification of Medical Devices in ASEAN (Third Edition, June 2025), covering decisions from the 4th to the 14th ASEAN Medical Device Technical Committee meetings, and updates it annually. Two examples from the list: an automated bloodborne pathogen test equipment is Class A, and a threshold-suspend artificial pancreas device system is Class C. If your device is on the list, use that class; otherwise apply the rules (see MDA classification).
Borderline products: is it a device at all?
The AMDC also decides whether products that sit between devices, medicines, cosmetics, supplements and protective equipment are medical devices. MDA publishes those decisions in MDA/GD/0063, Harmonised Borderline Products in ASEAN (Third Edition, June 2025), from the 5th to the 14th AMDTC meetings, and updates it yearly. A micropipette, for example, is a non-medical device unless its manufacturer states it is for IVD use. Software is the most common borderline question; see software as a medical device.
Post-market: the same three deadlines, one stricter tier
| Event | AMDD Annex 5 (recommended) | Act 737 s.40 (law in Malaysia) |
|---|---|---|
| Serious threat to public health | 48 hours | 48 hours from discovery |
| Led to death or serious deterioration in health | 10 days | 10 days |
| Could cause death or serious deterioration if it recurred | 30 days | 10 days |
| Device failure, deterioration, labelling or IFU inadequacy | Not a separate tier | 30 days |
Annex 5 says each regulator may adopt its recommendations or set its own, so check the national rule in every market. Malaysia’s applies to incidents inside or outside Malaysia. See MDA mandatory problem reporting and recalls and field corrective actions.
Regulators also share safety signals with each other. Under MDA/GD/0067, Medical Device Post Market Information Exchange for ASEAN Member States (First Edition, January 2024), adopted after the 12th AMDC meeting in Bandar Seri Begawan on 12–13 September 2023, a regulator reports events likely to cause a serious public health threat, national trend findings, or requests for information to the ASEAN Secretariat on a common template, and the Secretariat circulates it to all member states under the AMDD’s confidentiality article (Article 16). A safety problem found in one ASEAN country can reach MDA through this channel.
What the AMDD does not do
- No single ASEAN registration. Each country registers devices and licenses establishments under its own law (Articles 6 and 7).
- No obligation to accept another country’s approval. Reliance routes such as Malaysia’s HSA verification route are national decisions, not AMDD requirements.
- Countries keep their own controls. A state may refuse or restrict a compliant device for religious or cultural reasons, refuse refurbished devices, and set its own level of protection (Article 17).
- Paperwork details can differ. A state may require the Declaration of Conformity to be legalised or notarised (Annex 6), and may require labels in its national language (Article 10(3)).
Using it: one dossier, several ASEAN markets
For a manufacturer the practical value of the AMDD is that the core technical file is reusable. Build the CSDT once against the essential principles, classify with the shared rules and check the harmonised list, and keep one Declaration of Conformity carrying the Annex 6 elements: the attestation of conformity and classification, device identification, the class and rule, the validity date, the product owner and physical manufacturer, the QMS and product standards, and the authorised signatory. Then adapt the local layer for each market: registration holder, labelling language, any notarisation, and national post-market deadlines. For devices made in Malaysia and exported, MDA issues a Certificate of Free Sale only for MDA-registered devices.
Apakah ASEAN Medical Device Directive (AMDD)?
AMDD ialah perjanjian ASEAN yang ditandatangani di Bangkok pada 21 November 2014 dan berkuat kuasa mulai 1 Januari 2015 bagi negara anggota yang meratifikasinya. Ia menetapkan definisi peranti perubatan yang sama, empat kelas risiko (A–D), prinsip asas keselamatan dan prestasi, format dosier CSDT, sistem amaran pasca pasaran dan elemen Perisytiharan Pematuhan. Setiap negara masih mendaftar peranti di bawah undang-undang sendiri; di Malaysia melalui Akta 737 dan Peraturan-Peraturan Peranti Perubatan 2012. WhatsApp 010-206 2070.
Frequently asked questions
What is the ASEAN Medical Device Directive (AMDD)?
When did the AMDD come into force, and which version is current?
What are the AMDD risk classes?
Does an approval in another ASEAN country let me sell the device in Malaysia?
What is the ASEAN CSDT?
How do Malaysia’s problem-reporting deadlines compare with the AMDD?
Has Malaysia signed the AMDD?
Planning Malaysia as one of several ASEAN markets?
Send us your device description and existing technical file. We will check it against the ASEAN CSDT and Malaysia’s essential principles, confirm the class against the harmonised list, and register it with MDA, with the dossier kept reusable for your other ASEAN submissions.